[go: up one dir, main page]

Desai, 2023 - Google Patents

Multi-omic stratification of the missense variant and redox-sensitive cysteinome

Desai, 2023

View PDF
Document ID
2440084428890783667
Author
Desai H
Publication year

External Links

Snippet

Cysteine-directed chemoproteomic profiling methods yield high-throughput inventories of redox-sensitive and ligandable cysteine residues. They are enabling techniques for functional biology. Due to their nucleophilicity and sensitivity to alkylation, cysteines have …
Continue reading at escholarship.org (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/978—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids

Similar Documents

Publication Publication Date Title
Bach et al. Light-activatable, 2, 5-disubstituted tetrazoles for the proteome-wide profiling of aspartates and glutamates in living bacteria
Pak et al. Sensitive immunopeptidomics by leveraging available large-scale multi-HLA spectral libraries, data-independent acquisition, and MS/MS prediction
Chang et al. Advances in identification and validation of protein targets of natural products without chemical modification
Montgomery et al. Chemoproteomic profiling of lysine acetyltransferases highlights an expanded landscape of catalytic acetylation
Bertran-Vicente et al. Site-specifically phosphorylated lysine peptides
Backus Applications of reactive cysteine profiling
Desai et al. SP3-Enabled rapid and high coverage chemoproteomic identification of cell-state–dependent redox-sensitive cysteines
Kemper et al. Global profiling of phosphorylation-dependent changes in cysteine reactivity
Xue et al. Identification of direct tyrosine kinase substrates based on protein kinase assay-linked phosphoproteomics
Cabrera et al. Comparative analysis of mass-spectrometry-based proteomic methods for protein target discovery using a one-pot approach
Lill et al. Proteomics in the pharmaceutical and biotechnology industry: a look to the next decade
Musa et al. Comprehensive proteomic investigation of ebf1 heterozygosity in Pro-B lymphocytes utilizing data independent acquisition
Ursu et al. Hide and seek: Identification and confirmation of small molecule protein targets
Ramisetty et al. Unraveling the dynamics of protein interactions with quantitative mass spectrometry
Wang et al. Multi-protease strategy identifies three PE2 missing proteins in human testis tissue
Lorentzian et al. Origins and clinical relevance of proteoforms in pediatric malignancies
Staal et al. Proteomic profiling of high risk medulloblastoma reveals functional biology
Hardman et al. Extensive non-canonical phosphorylation in human cells revealed using strong-anion exchange-mediated phosphoproteomics
Desai et al. SP3‐FAIMS‐enabled high‐throughput quantitative profiling of the cysteinome
Fedoryshchak et al. Discovery of lipid-mediated protein–protein interactions in living cells using metabolic labeling with photoactivatable clickable probes
Wiest et al. Cu-catalyzed azide–alkyne–thiol reaction forms ubiquitous background in chemical proteomic studies
Zeng et al. Global mapping of metalloproteomes
Yang et al. Comparative reactivity profiling of cysteine-specific probes by chemoproteomics
Li et al. ACR-based probe for the quantitative profiling of histidine reactivity in the human proteome
Desai et al. Multi-omic stratification of the missense variant cysteinome